FGED Society
FGED Society, formerly known as the Functional Genomics Data Society, is a global non-profit organization dedicated to the advancement and standardization of data sharing, data management, and data analysis in the field of functional genomics. The society plays a pivotal role in developing guidelines and standards to facilitate the open sharing and interoperability of high-throughput genomics data. Its mission is to promote the understanding, integration, and application of functional genomics data for scientific research and innovation.
History[edit | edit source]
The FGED Society was established in the late 1990s, in response to the growing need for a standardized framework to manage the vast amounts of data being generated by functional genomics experiments. The society was initially focused on microarray data but has since expanded its scope to include other high-throughput technologies such as next-generation sequencing (NGS), RNA-Seq, and proteomics. Over the years, the FGED Society has been instrumental in developing and promoting data standards such as MIAME (Minimum Information About a Microarray Experiment) and MINSEQE (Minimum Information about a high-throughput Nucleotide Sequencing Experiment), which have been widely adopted by the scientific community and journals.
Mission and Goals[edit | edit source]
The primary mission of the FGED Society is to facilitate the sharing and proper use of functional genomics data through the development of standards and best practices. Its goals include:
- Promoting the open access of functional genomics data to accelerate scientific discovery.
- Developing and advocating for standards that ensure the reproducibility and comparability of experiments.
- Encouraging the adoption of these standards by journals, funding agencies, and research institutions.
- Providing a forum for the exchange of ideas and collaboration among researchers, bioinformaticians, and other stakeholders in the functional genomics community.
Activities and Initiatives[edit | edit source]
The FGED Society organizes workshops, conferences, and webinars to educate and update its members on the latest developments in functional genomics data management and analysis. It also collaborates with other organizations and consortia to align standards and promote interoperability among different data types and research disciplines. The society actively participates in the development of new technologies and methodologies that can enhance the utility and accessibility of functional genomics data.
Membership[edit | edit source]
Membership in the FGED Society is open to individuals and institutions involved in functional genomics research, including scientists, bioinformaticians, data managers, and policy makers. Members benefit from access to a network of experts, resources for data management and analysis, and opportunities to contribute to the development of standards and best practices in the field.
Impact[edit | edit source]
The work of the FGED Society has had a significant impact on the field of functional genomics. By promoting the standardization and open sharing of data, the society has contributed to the acceleration of scientific discovery and the advancement of personalized medicine. Its standards have been adopted by major journals and funding agencies, ensuring that the data underlying scientific publications are accessible and reusable.
Challenges and Future Directions[edit | edit source]
As functional genomics technologies continue to evolve, the FGED Society faces the challenge of keeping its standards and guidelines relevant and effective. The increasing complexity and volume of data, along with the emergence of new data types, require ongoing efforts to develop and refine data management and sharing practices. The society is also working to enhance the interoperability of functional genomics data with other biological and clinical data types, to support integrative and translational research efforts.
This article is a stub. You can help WikiMD by registering to expand it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD